Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles

Yersinia pestis enters host cells and evades host defenses, in part, through interactions between Yersinia pestis proteins and host membranes. One such interaction is through the type III secretion system, which uses a highly conserved and ordered complex for Yersinia pestis outer membrane effector protein translocation called the injectisome. The portion of the injectisome that interacts directly with host cell membranes is referred to as the translocon. The translocon is believed to form a pore allowing effector molecules to enter host cells. To facilitate mechanistic studies of the translocon, we have developed a cell-free approach for expressing translocon pore proteins as a complex supported in a bilayer membrane mimetic nano-scaffold known as a nanolipoprotein particle (NLP) Initial results show cell-free expression of Yersinia pestis outer membrane proteins YopB and YopD was enhanced in the presence of liposomes. However, these complexes tended to aggregate and precipitate. With the addition of co-expressed (NLP) forming components, the YopB and/or YopD complex was rendered soluble, increasing the yield of protein for biophysical studies. Biophysical methods such as Atomic Force Microscopy and Fluorescence Correlation Spectroscopy were used to confirm that the soluble YopB/D complex was associated with NLPs. An interaction between the YopB/D complex and NLP was validated by immunoprecipitation. The YopB/D translocon complex embedded in a NLP provides a platform for protein interaction studies between pathogen and host proteins. These studies will help elucidate the poorly understood mechanism which enables this pathogen to inject effector proteins into host cells, thus evading host defenses.

[1]  T. Laurence,et al.  Quantifying interactions of a membrane protein embedded in a lipid nanodisc using fluorescence correlation spectroscopy. , 2014, Biophysical journal.

[2]  T. Laurence,et al.  Characterizing diffusion dynamics of a membrane protein associated with nanolipoproteins using fluorescence correlation spectroscopy , 2011, Protein science : a publication of the Protein Society.

[3]  Andrey P. Anisimov,et al.  Amino acid and structural variability of Yersinia pestis LcrV protein. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[4]  T. Sulchek,et al.  Atomic force microscopy differentiates discrete size distributions between membrane protein containing and empty nanolipoprotein particles. , 2009, Biochimica et biophysica acta.

[5]  T. Sulchek,et al.  Cell-free Co-expression of Functional Membrane Proteins and Apolipoprotein, Forming Soluble Nanolipoprotein Particles*S , 2008, Molecular & Cellular Proteomics.

[6]  Vicki L. Walsworth,et al.  Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particles. , 2008, Journal of the American Chemical Society.

[7]  S. Smiley Immune defense against pneumonic plague , 2008, Immunological reviews.

[8]  J. Bliska,et al.  Vaccination of Mice with a Yop Translocon Complex Elicits Antibodies That Are Protective against Infection with F1−Yersinia pestis , 2008, Infection and Immunity.

[9]  T. Sulchek,et al.  Insertion of membrane proteins into discoidal membranes using a cell-free protein expression approach. , 2008, Journal of proteome research.

[10]  W. Swietnicki,et al.  Yersinia pestis YopD 150-287 fragment is partially unfolded in the native state. , 2008, Protein expression and purification.

[11]  T. Sulchek,et al.  Different apolipoproteins impact nanolipoprotein particle formation. , 2007, Journal of the American Chemical Society.

[12]  M. Aili,et al.  Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells. , 2007, Microbes and infection.

[13]  G. Cornelis,et al.  The type III secretion injectisome , 2006, Nature Reviews Microbiology.

[14]  V. Dötsch,et al.  Cell‐free expression as an emerging technique for the large scale production of integral membrane protein , 2006, The FEBS journal.

[15]  L. J. Mota Type III secretion gets an LcrV tip. , 2006, Trends in microbiology.

[16]  S. Müller,et al.  The V-Antigen of Yersinia Forms a Distinct Structure at the Tip of Injectisome Needles , 2005, Science.

[17]  G. Cornelis,et al.  Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. , 2005, The Journal of infectious diseases.

[18]  Michelle B. Ryndak,et al.  Role of Predicted Transmembrane Domains for Type III Translocation, Pore Formation, and Signaling by the Yersinia pseudotuberculosis YopB Protein , 2005, Infection and Immunity.

[19]  H. Wolf‐Watz,et al.  The YopD Translocator of Yersinia pseudotuberculosis Is a Multifunctional Protein Comprised of Discrete Domains , 2004, Journal of bacteriology.

[20]  C. Médigue,et al.  Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Brubaker Interleukin-10 and Inhibition of Innate Immunity to Yersiniae: Roles of Yops and LcrV (V Antigen) , 2003, Infection and Immunity.

[22]  I. Sethson,et al.  Conformational analysis by CD and NMR spectroscopy of a peptide encompassing the amphipathic domain of YopD from Yersinia. , 2002, European journal of biochemistry.

[23]  Tomio Ogasawara,et al.  A bilayer cell‐free protein synthesis system for high‐throughput screening of gene products , 2002, FEBS letters.

[24]  G. Plano,et al.  Type III export: new uses for an old pathway , 2001, Molecular microbiology.

[25]  R. Benz,et al.  LcrV is a channel size‐determining component of the Yop effector translocon of Yersinia , 2001, Molecular microbiology.

[26]  S. Miller,et al.  The Salmonella type III secretion translocon protein SspC is inserted into the epithelial cell plasma membrane upon infection , 2000, Molecular microbiology.

[27]  J. Ruysschaert,et al.  Yersinia enterocolitica type III secretion–translocationsystem: channel formation by secreted Yops , 1999, The EMBO journal.

[28]  S. Welkos,et al.  Protective Efficacy of RecombinantYersinia Outer Proteins against Bubonic Plague Caused by Encapsulated and Nonencapsulated Yersinia pestis , 1999, Infection and Immunity.

[29]  H. Wolf‐Watz,et al.  YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation , 1998, Molecular microbiology.

[30]  J. Galán,et al.  Supramolecular structure of the Salmonella typhimurium type III protein secretion system. , 1998, Science.

[31]  T. Bergman,et al.  YopB and YopD constitute a novel class of Yersinia Yop proteins , 1993, Infection and immunity.

[32]  M. Telepnev,et al.  The difference in the lcrV sequences between Y. pestis and Y. pseudotuberculosis and its application for characterization of Y. pseudotuberculosis strains. , 1992, Microbial pathogenesis.

[33]  T. Sulchek,et al.  Cell-free expression for nanolipoprotein particles: building a high-throughput membrane protein solubility platform. , 2009, Methods in molecular biology.

[34]  B. Rupp,et al.  Laboratory scale structural genomics , 2004, Journal of Structural and Functional Genomics.

[35]  A. Friedlander,et al.  Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. , 1999, Infection and immunity.